ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 602066 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 602066; 2) Community: the network communities that were significantly associated with the response to NSC 602066; 3) Molecule: the relationships between components within communities and NSC 602066; 4) MDR: the compounds that were significantly associated with the NSC 602066.

NSC Compound Enrichment Correlation
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.0174563696971637 0.71187093
NSC 106554 Musennin 0.0195202843390059 0.040977835
NSC 763582 Null 0.019520284339006 -0.43585931
NSC 600301 Null 0.0195202843390062 0.55701361
NSC 602130 13-Desoxyphomenone 0.0202245331784477 0.25240818
NSC 607281 Null 0.0202245331784477 0.44691323
NSC 619961 Primaquine diphosphate 0.0202245331784477 0.35314631
NSC 633273 ANTINEOPLASTIC-633273 0.0202245331784477 0.48864601
NSC 639516 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride 0.0202245331784477 0.67929196
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0202245331784477 0.81008348
Total:128  Current:62    [First] [Prev] [Next] [Last]